RBC Capital analyst Leonid Timashev examines how biotech M&A speculation, whether accurate or not, can move stocks and create tactical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE